Antidepressant Tolerability

Antidepressant Tolerability is a clinical construct that refers to the degree to which a patient can adhere to antidepressant pharmacotherapy without experiencing clinically significant adverse effects, distinguishing it from efficacy or pharmacokinetic properties within the evaluation of treatment outcomes.

538

Publications

32.4K

Citations

2.4K

Authors

800

Institutions

Publications per year

2017–2026

84

Publications

538

1–5 of 538

Authors

2.4K

  1. MF
    Maurizio Fava

    Massachusetts General Hospital, United States

    18 publications · 1.2K citations

    16

    h-index

  2. AJ
    A. John Rush

    The University of Texas Southwestern Medical Center, United States

    10 publications · 568 citations

    10

    h-index

  3. MH
    Madhukar H. Trivedi

    The University of Texas Southwestern Medical Center, United States

    10 publications · 762 citations

    10

    h-index

  4. DL
    David L. Dünner

    University of Washington, United States

    7 publications · 461 citations

    7

    h-index

  5. JP
    John P. Feighner

    San Diego Biomedical Research Institute, United States

    7 publications · 358 citations

    7

    h-index

1–5 of 2.4K

Venues

  1. PubMed

    Repository · 83 publications · 3.9K citations

    39

    h-index

  2. The Journal of Clinical Psychiatry

    36 publications · 3K citations

    28

    h-index

  3. Journal of Clinical Psychopharmacology

    34 publications · 3.1K citations

    26

    h-index

  4. International Clinical Psychopharmacology

    32 publications · 2.3K citations

    24

    h-index

  5. Acta Psychiatrica Scandinavica

    18 publications · 660 citations

    15

    h-index

1–5